Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuanghua Baihe Tablets for Recurrent Aphthous Ulcer
ChiCTR2000035206Phase 4Not yet recruiting
- Sponsor
- Peking University School and Hospital of Stomatology
- Start
- Sep 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in aphthosis (RAS) comparing Shuanghua Baihe Tablets with Placebo (2 arms). Primary endpoints: Ulcer size, Ulcer healing rate and 3 more. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
Shuanghua Baihe
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on ChiCTR2000035206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035206.